Artemisinin: A Versatile Weapon from Traditional Chinese Medicine

  • Thomas Efferth


Traditional Chinese medicine (TCM) commands a unique position among all traditional medicines because of its 5000 years of tradition. Our own interest in natural products from TCM was triggered in the 1990s by sesquiterpene lactones of the artemisinin type from Artemisia annua L. The first description of the Chinese herb Artemisia annua L. (qinghao, Sweet wormwood) dates back to 168 B.C.E. Artemisinin (qinghaosu) was identified in 1972 as the active antimalarial constituent of Artemisia annua L. Artemisinin and its derivatives are used for the treatment of malaria. As shown in recent years, this class of compounds also shows activity against cancer cells, schistosomiasis, and certain viruses, i.e., human cytomegalovirus, hepatitis B anc C virus, and bovine viral diarrhea virus. Interestingly, the bioactivity of artemisinin seems to be even broader and also includes the inhibition of other protozaons such as Leishmania, Trypanosoma, and Toxoplasma gondii, as well as some trematodes, fungi, yeast, and bacteria. The analysis of its complete profile of pharmacological activities, as well as the elucidation of molecular modes of action and the performance of clinical trials, will further elucidate the full potential of this versatile weapon from nature against diseases.


Artemisinin Cancer Chemotherapy Malaria Pharmacognosy Schistosomiasis Traditional Chinese medicine Viral infections 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Efferth T, Miyachi H, Bartsch H (2007a) Cancer Genom Proteom 4:81–91Google Scholar
  2. 2.
    Efferth T, Li PC, Konkimalla VS, Kaina B (2007b) Trends Mol Med 13:353–361Google Scholar
  3. 3.
    Efferth T, Fu YJ, Zu YG, Schwarz G, Konkimalla VS, Wink M (2007c) Curr Med Chem 14:2024–2032Google Scholar
  4. 4.
    Efferth T, Rücker G, Falkenberg M, Manns D, Olbrich A, Fabry U, Osieka R (1996) Arzneimittelforschung 46:196–200Google Scholar
  5. 5.
    Efferth T, Kaina B (2004) Cancer Genom Proteom 1:363–370Google Scholar
  6. 6.
    Efferth T, Olbrich A, Sauerbrey A, Ross DD, Gebhart E, Neugebauer M (2002a) Anticancer Res 22:4221–4224Google Scholar
  7. 7.
    Efferth T, Olbrich A, Bauer R (2002b) Biochem Pharmacol 64:617–623Google Scholar
  8. 8.
    Efferth T, Sauerbrey A, Halatsch ME, Ross DD, Gebhart E (2003a) Naunyn Schmiedebergs Arch Pharmacol 367:56–67Google Scholar
  9. 9.
    Efferth T, Rauh R, Kahl S, Tomicic M, Boechzelt H, Tome ME, Briehl MM, Bauer R, Kaina B (2005a) Biochem Pharmacol 69:811–818Google Scholar
  10. 10.
    Efferth T, Chen T, Kaina B, Wang G (2005b) Cancer Genomics Proteomics 2:115–124Google Scholar
  11. 11.
    Efferth T (2005) Oncol Rep 13:459–463Google Scholar
  12. 12.
    Rinner B, Siegl V, Pürstner P, Efferth T, Brem B, Greger H, Pfragner R (2004) Anticancer Res 24:495–500Google Scholar
  13. 13.
    Adams M, Efferth T, Bauer R (2006) Planta Med 72:862–864Google Scholar
  14. 14.
    Adams M, Mahringer A, Bauer R, Fricker G, Efferth T (2007a) Planta Med 73:1475–1478Google Scholar
  15. 15.
    Adams M, Mahringer A, Fricker G, Efferth T, Bauer R (2007b) Planta Med 73:1154–1157Google Scholar
  16. 16.
    Konkimalla VB, Efferth T (2008) Anti–cancer natural product library from traditional Chinese medicine. Combinat Chem High Throughput Screening 11:7–15Google Scholar
  17. 17.
    Konkimalla VB, Suhas VL, Chandra NR, Gebhart E, Efferth T (2007) Expert Rev Anticancer Ther 7:317–329Google Scholar
  18. 18.
    Rauh R, Kahl S, Boechzelt H, Bauer R, Kaina B, Efferth T (2007) Chin Med 2:8Google Scholar
  19. 19.
    Romero MR, Serrano MA, Efferth T, Alvarez M, Marin JJ (2007) Planta Med 73:552–558Google Scholar
  20. 20.
    Wang J, Zheng Y, Efferth T, Wang R, Shen Y, Hao X (2005) Phytochemistry 66:697–701Google Scholar
  21. 21.
    Wang YF, Cao JX, Efferth T, Lai GF, Luo SD (2006a) Chem Biodivers 3:646–653Google Scholar
  22. 22.
    Wang YF, Lai GF, Efferth T, Cao JX, Luo SD (2006b) Chem Biodivers 3:1023–1030Google Scholar
  23. 23.
    Hsu E (2006) Br J Clin Pharmacol 61:666–670Google Scholar
  24. 24.
    Klayman DL (1985) Science 228:1049–1055Google Scholar
  25. 25.
    Li Y, Wu YL (1998) Med Trop 58 Suppl 3:9S–12SGoogle Scholar
  26. 26.
    Yeung S, Pongtavornpinyo W, Hastings IM, Mills AJ, White NJ (2004) Am J Trop Med Hyg 71(2 Suppl):179–186Google Scholar
  27. 27.
    Semenov A, Olson JE, Rosenthal PJ (1998) Antimicrob Agents Chemother 42:2554–2558Google Scholar
  28. 28.
    Shenai BR, Sijwali PS, Singh A, Rosenthal PJ (2000) J Biol Chem 275:29000–29010Google Scholar
  29. 29.
    Berman PA, Adams PA (1997) Free Radic Biol Med 22:1283–1288Google Scholar
  30. 30.
    O’Neill PM, Posner GH (2004) J Med Chem 47:2945–2964Google Scholar
  31. 31.
    Posner GH, Oh CH (1992) J Am Chem Soc 114:8328–8329Google Scholar
  32. 32.
    Meshnick SR, Yang YZ, Lima V, Kuypers F, Kamchonwongpaisan S, Yuthavong Y (1993) Antimicrob Agents Chemother 37:1108–1114Google Scholar
  33. 33.
    Butler AR, Gilbert BC, Hulme P, Irvine LR, Renton L, Whitwood AC (1998) Free Radic Res 28:471–476Google Scholar
  34. 34.
    Shterman N, Kupfer B, Moroz C (1991) Pathobiology 59:19–25Google Scholar
  35. 35.
    Payne AG (2003) Med Hypotheses 61:206–209Google Scholar
  36. 36.
    Moore JC, Lai H, Li JR, Ren RL, McDougall JA, Singh NP, Chou CK (1995) Cancer Lett 98:83–87Google Scholar
  37. 37.
    Efferth T, Benakis A, Romero MR, Tomicic M, Rauh R, Steinbach D, Hafer R, Stamminger T, Oesch F, Kaina B, Marschall M (2004a) Free Radic Biol Med 37:998–1009Google Scholar
  38. 38.
    Aulbert E, Disselhoff W, Sorje H, Schulz E, Gericke D (1980) Eur J Cancer 16:1217–1232Google Scholar
  39. 39.
    Gatter KC, Brown G, Trowbridge IS, Woolston RE, Mason DY (1983) J Clin Pathol36:539–545Google Scholar
  40. 40.
    Judd W, Poodry CA, Strominger JL (1980) J Exp Med 152:1430–1435Google Scholar
  41. 41.
    Trowbridge IS, Omary MB (1981) Proc Natl Acad Sci USA 78:3039–3043Google Scholar
  42. 42.
    Sutherland R, Delia D, Schneider C, Newman R, Kemshead J, Greaves M (1981) Proc Natl Acad Sci USA 78:4515–4519Google Scholar
  43. 43.
    Butler D (1997) Nature 386:535–541Google Scholar
  44. 44.
    WHO (2000) Trans R Soc Trop Med Hyg 94:S1–S75Google Scholar
  45. 45.
    White NJ (2004) J Clin Invest 113:1084–1092Google Scholar
  46. 46.
    Silachamroon U, Krudsood S, Phophak N, Looareesuwan S (2002) KoreanJ Parasitol 40:1–7Google Scholar
  47. 47.
    Mutabingwa TK (2005) Acta Trop 95:305–315Google Scholar
  48. 48.
    White N (1999) Philos Trans R Soc London B Biol Sci 354:739–749Google Scholar
  49. 49.
    Mishra SK, Asthana OP, Mohanty S, Patnaik JK, Das BS, Srivastava JS, Satpathy SK, Dash S, Rath PK, Varghese K (1995) Trans R Soc Trop Med Hyg 89:299–302Google Scholar
  50. 50.
    Mohanty S, Mishra SK, Satpathy SK, Satpathy S, Patnaik JK (1997) Trans R Soc Trop Med Hyg 91:328–330Google Scholar
  51. 51.
    Price R, van Vugt M, Nosten F, Luxemburger C, Brockman A, Phaipun L, Chongsuphajaisiddhi T, White N (1998) Am J Trop Med Hyg 59:883–888Google Scholar
  52. 52.
    Mohanty S, Patel DK, Pati SS, Mishra SK (2006) Indian J Med Res 124:245–260Google Scholar
  53. 53.
    Ribeiro IR, Olliaro P (1998) Med Trop (Mars) 58:50–53Google Scholar
  54. 54.
    Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N (2004) Lancet 363:9–17Google Scholar
  55. 55.
    Davies TME, Karunajeewa HA, Ilett KF (2005) Med J Aust 182:181–185Google Scholar
  56. 56.
    Bar–Zeev N, White N (2006) J Trop Pediatr 52:78–82Google Scholar
  57. 57.
    Bakshi R, Hermeling–Fritz I, Gathmann I, Alteri E (2000) Trans R Soc Trop Med Hyg 94:419–424Google Scholar
  58. 58.
    Omari AA, Gamble C, Garner P (2005) Cochrane Database Syst Rev 19:CD005564Google Scholar
  59. 59.
    Bukirwa H, Critchley J (2006) Cochrane Database Syst Rev 25:CD004966Google Scholar
  60. 60.
    Obonyo CO, Juma EA, Ogutu BR, Vulule JM, Lau J (2007) Trans R Soc Trop Med Hyg 101:117–126Google Scholar
  61. 61.
    Efferth T (2005a) Drug Resist Updat 8:85–97Google Scholar
  62. 62.
    Efferth T (2006) Curr Drug Targets 7:407–421Google Scholar
  63. 63.
    Efferth T (2007) Planta Med 73:299–309Google Scholar
  64. 64.
    Efferth T, Oesch F (2004) Biochem Pharmacol 68:3–10Google Scholar
  65. 65.
    Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR (2001) Int J Oncol18:767–773Google Scholar
  66. 66.
    Efferth T, Davey M, Olbrich A, Rücker G, Gebhart E, Davey R (2002b) Blood Cells Mol Dis 28:160–168Google Scholar
  67. 67.
    Efferth T, Ramirez T, Gebhart E, Halatsch ME (2004b) Biochem Pharmacol 67:1689–1700Google Scholar
  68. 68.
    Efferth T, Briehl MM, Tome ME (2003b) Int J Oncol 23:1231–1235Google Scholar
  69. 69.
    Efferth T, Sauerbrey A, Olbrich A, Gebhart E, Rauch P, Weber HO, Hengstler JG, Halatsch ME, Volm M, Tew KD, Ross DD, Funk JO (2003c) Mol Pharmacol 64:382–394Google Scholar
  70. 70.
    Efferth T, Volm M (2005) In Vivo 19:225–232Google Scholar
  71. 71.
    Aisen P (2004) Int J Biochem Cell Biol 36:2137–2143Google Scholar
  72. 72.
    Kelter G, Steinbach D, Konkimalla VB, Tahara T, Taketani S, Fiebig HH, Efferth T (2007) PLoS ONE 2:e798Google Scholar
  73. 73.
    Singh NP, Lai H (2001) Life Sci 70:49–56Google Scholar
  74. 74.
    Lai H, Sasaki T, Singh NP, Messay A (2005) Life Sci 76:1267–1279Google Scholar
  75. 75.
    Folkman J (1992) Semin Cancer Biol 3:65–71Google Scholar
  76. 76.
    Kerbel R, Folkman J (2002) Nat Rev Cancer 2:727–739Google Scholar
  77. 77.
    Chen HH, Zhou HJ, Fang X (2003) Pharmacol Res 48:231–236Google Scholar
  78. 78.
    Chen HH, Zhou HJ, Wang WQ, Wu GD (2004a) Cancer Chemother Pharmacol 53:423–432Google Scholar
  79. 79.
    Chen HH, Zhou HJ, Wu GD, Lou XE (2004b) Pharmacology 71:1–9.Google Scholar
  80. 80.
    Dell’Eva R, Pfeffer U, Vene R, Anfosso L, Forlani A, Albini A, Efferth T (2004) Biochem Pharmacol 68:2359–2366Google Scholar
  81. 81.
    Huan-huan C, Li-Li Y, Shang-Bin L (2004) Cancer Lett 211:163–173Google Scholar
  82. 82.
    Anfosso L, Efferth T, Albini A, Pfeffer U (2006) Pharmacogenomics J 6:269–278Google Scholar
  83. 83.
    Li Y, Shan F, Wu JM, Wu GS, Ding J, Xiao D, Yang WY, Atassi G, Leonce S, Caignard DH, Renard P (2001) Bioorg Med Chem Lett 11:5–8Google Scholar
  84. 84.
    Sadava D, Phillips T, Lin C, Kane SE (2002) Cancer Lett 179:151–156Google Scholar
  85. 85.
    Wang Q, Wu LM, Zhao Y, Zhang XL, Wang NP (2002) Yao Xue Xue Bao 37:477–478Google Scholar
  86. 86.
    Singh NP, Lai HC (2004) Anticancer Res 24:2277–2280Google Scholar
  87. 87.
    Yamachika E, Habte T, Oda D (2004) Anticancer Res 24:2153–2160Google Scholar
  88. 88.
    Efferth T, Giaisi M, Merling A, Krammer PH, Li-Weber M (2007d) PLoS ONE 2:e693Google Scholar
  89. 89.
    Disbrow GL, Baege AC, Kierpiec KA, Yuan H, Centeno JA, Thibodeaux CA, Hartmann D, Schlegel R (2005) Cancer Res 65:10854–10861Google Scholar
  90. 90.
    Lai H, Singh NP (2006) Cancer Lett 231:43–48Google Scholar
  91. 91.
    Berger TG, Dieckmann D, Efferth T, Schultz ES, Funk JO, Baur A, Schuler G (2005) Oncol Rep 14:1599–1603Google Scholar
  92. 92.
    Singh N, Verma K (2002) Arch Oncol 10:279–280Google Scholar
  93. 93.
    Singh NP, Panwar VK (2006) Integr Cancer Ther 5:391–394Google Scholar
  94. 94.
    Ross AGP, Bartley PM, Sleigh AC, Olds GR, Li YS, Williams GM, McManus DP (2002) N Engl J Med 346:1212–1220Google Scholar
  95. 95.
    Gryseels B, Polman K, Clerinx J, Kestens L (2006) Lancet 368:1106–1118Google Scholar
  96. 96.
    Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Lancet Infect Dis 6:411–425Google Scholar
  97. 97.
    Engels D, Chitsulo L, Montresor A, Savioli L (2002) Acta Trop 82:139–146Google Scholar
  98. 98.
    WHO (2002) WHO Tech Rep Ser, p 912Google Scholar
  99. 99.
    Chen DJ, Fu LF, Shao PP, Wu FZ, Fan CZ, Shu H, Ren CX, Sheng XL (1980) Zhong Hui Yi Xue Zha Zhi 60:422–425Google Scholar
  100. 100.
    Utzinger J, Xiao SH, Tanner M, Keiser J (2007) Curr Opin Investig Drugs 8:105–116Google Scholar
  101. 101.
    Utzinger J, Xiao SH, Keiser J, Chen MG, Zheng J, Tanner M (2001) Curr Med Chem 8:1841–1860Google Scholar
  102. 102.
    Utzinger J, Keiser J, Xiao SH, Tanner M, Singer BH (2003) Antimicrob Agents Chemother 47:1487–1495Google Scholar
  103. 103.
    Utzinger J, Zhou XN, Chen MG, Bergquist R (2005) Acta Trop 96:69–96Google Scholar
  104. 104.
    Xiao SH (2005) Acta Trop 96:153–167Google Scholar
  105. 105.
    Efferth T, Marschall M, Wang X, Huong SM, Hauber I, Olbrich A, Kronschnabl M, Stamminger T, Huang ES (2002c) J Mol Med 80:233–242Google Scholar
  106. 106.
    Britt WJ, Alford CA (1996) Cytomegalovirus. In: Fields BN, Knipe DM, Howley PM (eds) Fields Virology, 3rd edn. Lippincott-Raven, Philadelphia, pp 2493–2523Google Scholar
  107. 107.
    Stratta RJ, Shaeffer MS, Markin RS, Wood RP, Langnas AN, Reed EC, Doonovan JP, Woods GL, Bradshaw KA, Pillen TJ, Shaw BW Jr (1992) Dig Dis Sci 37:673–688Google Scholar
  108. 108.
    Shen CY, Ho MS, Chang SF, Yen MS, Ng HAT, Huang ES, Wu CW (1993) J Infect Dis 168:449–452Google Scholar
  109. 109.
    Crumpacker CS (1996) N Engl J Med 355:721–729Google Scholar
  110. 110.
    Chrisp P, Clissold SP (1991) Drugs 41:104–129Google Scholar
  111. 111.
    Hitchcock MJM, Jaffe HS, Martin JC, Stagg RJ (1996) Antimicrob Agents Chemother 7:115–127Google Scholar
  112. 112.
    Polis MA, Spooner KM, Baird BFM, Manischewitz JF, Jaffe HS, Fisher PE, Fallon J, Davey RT Jr, Kovacs JA, Walker RE, Whitcup SM, Nussenblatt RB, Lane HC, Masur H (1995) Antimicrob Agents Chemother 39:882–886Google Scholar
  113. 113.
    Erice A (1999) Clin Microbiol Rev 12:286–297Google Scholar
  114. 114.
    Marchini A, Liu H, Zhu H (2001) J Virol 75:1870–1878Google Scholar
  115. 115.
    Ghazal P, Lubon H, Fleckenstein B, Henninghausen L (1987) Proc Natl Acad Sci USA 84:3658–3662Google Scholar
  116. 116.
    Yurochko AD, Kowalik TF, Huong SM, Huang ES (1995) J Virol 69:5391–5400Google Scholar
  117. 117.
    Yurochko AD, Mayo MW, Poma EE, Baldwin AS Jr, Huang ES (1997) J Virol71:4638–4648Google Scholar
  118. 118.
    Johnson RA, Wang X, Ma X-L, Huong S-M, Huang E-S (2001) J Virol 75:6022–6032Google Scholar
  119. 119.
    Chou S, Marousek G, Guentzel S, Follansbee SE, Poscher ME, Lalezari JP, Miner RC, Drew WL (1997) J Infect Dis 176:786–789Google Scholar
  120. 120.
    Scott GM, Weinberg A, Rawlinson WD, Chou S (2007) Antimicrob Agents Chemother 51:89–94Google Scholar
  121. 121.
    Kaptein SJ, Efferth T, Leis M, Rechter S, Auerochs S, Kalmer M, Bruggeman CA, Vink C, Stamminger T, Marschall M (2006) Antiviral Res 69:60–69Google Scholar
  122. 122.
    Alejo E (1999) Clin Microbiol Rev 12:286–297Google Scholar
  123. 123.
    Fang CT, Nath N, Pielech M, Dodd RY (1981) J Virol Methods 2:349–356Google Scholar
  124. 124.
    Lien J, Petcu DJ, Aldrich CE, Mason WS (1987) J Virol 61:3832–3840Google Scholar
  125. 125.
    Wang GH, Seeger C (1993) J Virol 67:6507–6512Google Scholar
  126. 126.
    Molnar-Kimber KL, Summers JW, Mason WS (1984) J Virol 51:181–191Google Scholar
  127. 127.
    Bartholomeusz A, Locarnini S (2001) Hepatology 34:432–435Google Scholar
  128. 128.
    Iino S (2002) Oncology 62 (Suppl 1):18–23Google Scholar
  129. 129.
    Beasley RP, Hwang LY (1991) Overview on the epidemiology of hepatocellular carcinoma. In: Hollinger FB, Lemon SM, Margolis M (eds) Viral Hepatitis and Liver Disease. Williams and Willkins, Baltimore, pp. 532–535Google Scholar
  130. 130.
    EASL Jury (2003) J Hepatol 38:533–540Google Scholar
  131. 131.
    Romero MR, Efferth T, Serrano MA, Castano B, Macias RI, Briz O, Marin JJ (2005) Antiviral Res 68:75–83Google Scholar
  132. 132.
    Batty KT, Davis TM, Thu LT, Binh TQ, Anh TK, Ilett KF (1996) J Chromatogr B Biomed Appl 677:345–350Google Scholar
  133. 133.
    Placidi L, Faraj A, Loi AG, Pierra C, Egron D, Cretton-Scott E, Gosselin G, Perigaud C, Martin LT, Schinazi RF, Imbach JL, el Kouni MH, Bryant ML, Sommadossi JP (2001) Antivir Chem Chemother 12:99–108Google Scholar
  134. 134.
    Romero MR, Martinez-Diez MC, Larena MG, Macias RIR, Dominguez M, Garcia-Monzon C, Serrano MA, Marin JJG (2002) Antivir Chem Chemother 13:371–380Google Scholar
  135. 135.
    Chouteau P, Le Seyec J, Saulier-Le Drean B, Cannie I, Brissot P, Lescoat G, Guguen-Guillouzo C, Gripon P (2001) J Hepatol 34:108–113Google Scholar
  136. 136.
    Paeshuyse J, Coelmont L, Vliegen I, Van Hemel J, Vandenkerckhove J, Peys E, Sas B, De Clercq E, Neyts J (2006) Biochem Biophys Res Commun 348:139–144Google Scholar
  137. 137.
    Fillebeen C, Rivas-Estilla AM, Bisaillon M, Ponka P, Muckenthaler M, Hentze MW, Koromilas AE, Pantopoulos K (2005) J Biol Chem 280:9049–9057Google Scholar
  138. 138.
    Tanikawa K (2004) Hepatobiliary Pancreat Dis Int 3:17–20Google Scholar
  139. 139.
    Buckwold VE, Beer BE, Donis RO (2003) Antiviral Res 60:1–15Google Scholar
  140. 140.
    Behrens SE, Grassmann CW, Thiel HJ, Meyers G, Tautz N (1998) J Virol 72:2364–2372Google Scholar
  141. 141.
    McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK (1998) N Engl J Med 339:1485–1492Google Scholar
  142. 142.
    Samuel CE (2001) Clin Microbiol Rev 14:778–809Google Scholar
  143. 143.
    Durantel D, Carrouee-Durantel S, Branza-Nichita N, Dwek RA, Zitzmann N (2004) Antimicrob Agents Chemother 48:497–504Google Scholar
  144. 144.
    Lau JY, Tam RC, Liang TJ, Hong Z (2002) Hepatology 35:1002–1009Google Scholar
  145. 145.
    Yang YZ, Little B, Meshnick SR (1994) Biochem Pharmacol 48:569–573Google Scholar
  146. 146.
    Romero MR, Serrano MA, Vallejo M, Efferth T, Alvarez M, Marin JJ (2006) Planta Med 72:1169–1174Google Scholar
  147. 147.
    Tam RC, Lau JY, Hong Z (2001) Antivir Chem Chemother 12:261–272Google Scholar
  148. 148.
    Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (2007) Lancet370:890–907Google Scholar
  149. 149.
    Naesens L, Bonnafous P, Agut H, De Clercq E (2006) J Clin Virol 37(Suppl 1):S69–75Google Scholar
  150. 150.
    Toovey S (2006) Toxicol Lett 166:95–104Google Scholar
  151. 151.
    Brewer TG, Grate SJ, Peggins JO, Weina PJ, Petras JM, Levine BS, Heiffer MH, Schuster BG (1994a) Am J Trop Med Hyg 51:251–259Google Scholar
  152. 152.
    Brewer TG, Peggins JO, Grate SJ, Petras JM, Levine BS, Weina PJ, Swearengen J, Heiffer MH, Schuster BG (1994b) Trans R Soc Trop Med Hyg 88 (Suppl 1):S33–S36Google Scholar
  153. 153.
    Kamchonwongpaisan S, McKeever P, Hossler P, Ziffer H, Meshnick SR (1997) Am J Trop Med Hyg 56:7–12Google Scholar
  154. 154.
    Genovese RF, Newman DB, Li Q, Peggins JO, Brewer TG (1998a) Brain Res Bull45:199–202Google Scholar
  155. 155.
    Jones-Brando L, D’Angelo J, Posner GH, Yolken R (2006) Antimicrob Agents Chemother 50:4206–4208Google Scholar
  156. 156.
    Panossian LA, Garga NI, Pelletier D (2005) Ann Neurol 58:812–813Google Scholar
  157. 157.
    Petras JM, Young GD, Bauman RA, Kyle DE, Gettayacamin M, Webster HK, Corcoran KD, Peggins JO, Vane MA, Brewer TG (2000) Anat Embryol 201:383–397Google Scholar
  158. 158.
    Li QC, Mog SR, Si YZ, Kyle DE, Gettayacamin M, Milhous WK (2002) Am J Trop Med Hyg 66:516–525Google Scholar
  159. 159.
    van Hensbroek MB, Onyiorah E, Jaffar S, Schneider G, Palmer A, Frenkel J, Enwere G, Forck S, Nusmeijer A, Bennett S, Greenwood B, Kwiatkowski D (1996) N Engl J Med 335:69–75Google Scholar
  160. 160.
    Stepniewska K, Day N, Babiker A, Lalloo D, Warrell D, Olliaro P, White N (2001) Trans R Soc Trop Med Hyg 95:637–650Google Scholar
  161. 161.
    Dondorp A, Nosten F, Stepniewska K, Day N, White N (2005) Lancet 366:717–725Google Scholar
  162. 162.
    Chang HR, Pechere JC (1988) Trans R Soc Trop Med Hyg 82:867Google Scholar
  163. 163.
    Ke OY, Krug EC, Marr JJ, Berens RL (1990) Antimicrob Agents Chemother 34:1961–1965Google Scholar
  164. 164.
    Genovese RF, Newman DB, Petras JM, Brewer TG (1998b) Pharmacol Biochem Behav 60:449–458Google Scholar
  165. 165.
    Berens RL, Krug EC, Nash PB, Curiel TJ (1998) J Infect Dis 177:1128–1131Google Scholar
  166. 166.
    Son ES, Song KJ, Shin JC, Nam HW (2001) Korean J Parasitol 39:133–141Google Scholar
  167. 167.
    Holfels E, McAuley J, Mack D, Milhous WK, McLeod R (1994) Antimicrob Agents Chemother 38:1392–1396Google Scholar
  168. 168.
    Nagamune K, Beatty WL, Sibley LD (2007a) Epub ahead of printGoogle Scholar
  169. 169.
    Nagamune K, Moreno SN, Sibley LD (2007b) Epub ahead of printGoogle Scholar
  170. 170.
    Yang DM, Liew FY (1993) Parasitology 106 (Pt 1):7–11Google Scholar
  171. 171.
    Avery MA, Muraleedharan KM, Desai PV, Bandyopadhyaya AK, Furtado MM, Tekwani BL (2003) J Med Chem 46:4244–4258Google Scholar
  172. 172.
    Menon RB, Kannoth MM, Tekwani BL, Gut J, Rosenthal PJ, Avery MA (2006) Comb Chem High Throughput Screen 9:729–741Google Scholar
  173. 173.
    Sen R, Bandyopadhyay S, Dutta A, Mandal G, Ganguly S, Saha P, Chatterjee M (2007) J Med Microbiol 56(Pt 9):1213–1218Google Scholar
  174. 174.
    Mishina YV, Krishna S, Haynes RK, Meade JC (2007) Antimicrob Agents Chemother 51:1852–1854Google Scholar
  175. 175.
    Kim JT, Park JY, Seo HS, Oh HG, Noh JW, Kim JH, Kim DY, Youn HJ (2002) Vet Parasitol 103:53–63Google Scholar
  176. 176.
    Allen PC, Danforth HD, Augustine PC (1998) Int J Parasitol 28:1131–1140Google Scholar
  177. 177.
    Keiser J, Brun R, Fried B, Utzinger J (2006) Antimicrob Agents Chemother 50:803–805Google Scholar
  178. 178.
    Merali S, Meshnick SR (1991) Antimicrob Agents Chemother 35:1225–1227Google Scholar
  179. 179.
    Tang HQ, Hu J, Yang L, Tan RX (2000) Planta Med 66:391–393Google Scholar
  180. 180.
    Galal AM, Ross SA, Jacob M, ElSohly MA (2005) J Nat Prod 68:1274–1276Google Scholar
  181. 181.
    Li W, Mo W, Shen D, Sun L, Wang J, Lu S, Gitschier JM, Zhou B (2005) PLoS Genet 1:e36Google Scholar
  182. 182.
    Murray CK, Ellis MW, Hospenthal DR (2004) Am J Trop Med Hyg 71:685–686Google Scholar
  183. 183.
    Shoeb HA, Tawfik AF, Shibl AM, el-Feraly FS (1990) J Chemother 2:362–367Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • Thomas Efferth
    • 1
  1. 1.German Cancer Research Center Pharmaceutical Biology (C015)Germany

Personalised recommendations